Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ: OPRX )

7.000 -0.150 (-2.10%)
Streaming Delayed Price Updated: 11:55 AM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 4 Next >
Unusual volume stocks in Thursday's session
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill
Top movers in Wednesday's session
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements. 
Via Chartmill
Which stocks are experiencing notable movement on Wednesday?
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Where OptimizeRx Stands With Analysts
Via Benzinga
The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Preview: OptimizeRx's Earnings
Via Benzinga
A Closer Look at 5 Analyst Recommendations For OptimizeRx
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million
OptimizeRx reports sales of $32.32M in Q4, beating consensus, with adjusted EPS of $0.30. Full-year revenue increased 29% and EBITDA grew 53%. 
Via Benzinga
CrowdStrike To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know
Via Benzinga
Expert Ratings For OptimizeRx
Via Benzinga
Where OptimizeRx Stands With Analysts
Via Benzinga
Earnings Scheduled For March 12, 2025
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023
OPRX stock results show that OptimizeRx beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
OptimizeRx Earnings Preview
Via Benzinga
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
OPRX Stock Earnings: OptimizeRx Beats EPS, Misses Revenue for Q2 2024
OPRX stock results show that OptimizeRx beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Gold Rises Over 1%; Arcos Dorados Shares Fall After Q1 Results
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Surges 150 Points; Retail Sales Flat For April
Via Benzinga
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024
OPRX stock results show that OptimizeRx beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
7 Top Undervalued Stocks Primed for a Multibagger Recovery
These seven undervalued stocks are trading at discounted prices but have the potential to deliver multibagger returns in the coming years. 
Via InvestorPlace
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.